Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Combination therapy Hepatitis C Peginterferon alfa-2a
DOI: 10.3350/cmh.2015.21.2.125 Publication Date: 2015-07-01T03:19:16Z
ABSTRACT
See the commentary-article "Hepatitis C virus infection in patients with hemophilia Korea: Is antiviral therapy effective and safe?" on page 122.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (19)
CITATIONS (4)